Halpern M, Gupta A, Zaghloul N, Thulasingam S, Calton C, Camp S
Biomedicines. 2024; 12(5).
PMID: 38790933
PMC: 11118767.
DOI: 10.3390/biomedicines12050970.
Fareed M, Khalid H, Khalid S, Shityakov S
Curr Mol Med. 2023; 24(9):1124-1134.
PMID: 37818557
DOI: 10.2174/0115665240257603230919103539.
Zhang Q, Luo T, Yuan D, Liu J, Fu Y, Yuan J
Sci Rep. 2023; 13(1):6002.
PMID: 37045911
PMC: 10092933.
DOI: 10.1038/s41598-023-31439-5.
Morfino P, Aimo A, Castiglione V, Galvez-Monton C, Emdin M, Bayes-Genis A
Heart Fail Rev. 2022; 28(2):555-569.
PMID: 36221014
PMC: 9553301.
DOI: 10.1007/s10741-022-10279-x.
Xiao Y, Vazquez-Padron R, Martinez L, Singer H, Woltmann D, Salman L
J Vasc Access. 2022; 25(2):390-406.
PMID: 35751379
PMC: 9974241.
DOI: 10.1177/11297298221085458.
TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis.
Yu X, Sun Q, Zhang Y, Zou L, Zhao Y
Front Pharmacol. 2022; 13:860588.
PMID: 35401211
PMC: 8987592.
DOI: 10.3389/fphar.2022.860588.
Microparticles in systemic sclerosis, targets or tools to control fibrosis: This is the question!.
colic J, Cerinic M, Guiducci S, Damjanov N
J Scleroderma Relat Disord. 2022; 5(1):6-20.
PMID: 35382401
PMC: 8922594.
DOI: 10.1177/2397198319857356.
Necrotizing Enterocolitis: LPS/TLR4-Induced Crosstalk Between Canonical TGF-β/Wnt/β-Catenin Pathways and PPARγ.
Gomart A, Vallee A, Lecarpentier Y
Front Pediatr. 2021; 9:713344.
PMID: 34712628
PMC: 8547806.
DOI: 10.3389/fped.2021.713344.
Evaluation of the Therapeutic Effects of Protocatechuic Aldehyde in Diabetic Nephropathy.
Chang Y, Chung M, Hsieh C, Shieh J, Wu M
Toxins (Basel). 2021; 13(8).
PMID: 34437430
PMC: 8402415.
DOI: 10.3390/toxins13080560.
Mesenchymal Stem Cells Suppress TGF-β Release to Decrease α-SMA Expression in Ameliorating CCl4-Induced Liver Fibrosis.
Hermansyah D, Putra A, Muradi Muhar A, Retnaningsih , Wirastuti K, Dirja B
Med Arch. 2021; 75(1):16-22.
PMID: 34012193
PMC: 8116080.
DOI: 10.5455/medarh.2021.75.16-22.
Therapeutic targeting of argininosuccinate synthase 1 (ASS1)-deficient pulmonary fibrosis.
Li J, Yang D, Oldham J, Linderholm A, Zhang J, Liu J
Mol Ther. 2021; 29(4):1487-1500.
PMID: 33508432
PMC: 8058484.
DOI: 10.1016/j.ymthe.2021.01.028.
Apoptosis and fibrosis of vascular smooth muscle cells in aortic dissection: an immunohistochemical study.
Lee J, Kim J, Lee S, Kim Y, Maeng Y, Park K
Int J Clin Exp Pathol. 2020; 13(8):1962-1969.
PMID: 32922591
PMC: 7476953.
Higher intestinal and circulatory lactate associated NOX2 activation leads to an ectopic fibrotic pathology following microcystin co-exposure in murine fatty liver disease.
Sarkar S, Saha P, Seth R, Mondal A, Bose D, Kimono D
Comp Biochem Physiol C Toxicol Pharmacol. 2020; 238:108854.
PMID: 32781293
PMC: 7541568.
DOI: 10.1016/j.cbpc.2020.108854.
Therapeutic potential of targeting kinase inhibition in patients with idiopathic pulmonary fibrosis.
Kim S, Lim J, Woo C
Yeungnam Univ J Med. 2020; 37(4):269-276.
PMID: 32693446
PMC: 7606966.
DOI: 10.12701/yujm.2020.00458.
Exon skipping of TGFβRI affects signalling and ECM expression in hypertrophic scar-derived fibroblasts.
Raktoe R, Rietveld M, Out-Luiting J, Kruithof-de Julio M, van Zuijlen P, van Doorn R
Scars Burn Heal. 2020; 6:2059513120908857.
PMID: 32528734
PMC: 7263111.
DOI: 10.1177/2059513120908857.
miR-136 improves renal fibrosis in diabetic rats by targeting down-regulation of tyrosine kinase SYK and inhibition of TGF-β1/Smad3 signaling pathway.
Liu L, Pang X, Shang W, Feng G, Wang Z, Wang J
Ren Fail. 2020; 42(1):513-522.
PMID: 32441195
PMC: 7946058.
DOI: 10.1080/0886022X.2020.1764854.
Identification of a transforming growth factor-β type I receptor transcript in Eriocheir sinensis and its molting-related expression in muscle tissues.
Tian Z, Peng H, Deng W, Jiao C
Mol Biol Rep. 2019; 47(1):77-86.
PMID: 31571110
DOI: 10.1007/s11033-019-05108-8.
Small-Molecule Inhibition of Glucose Transporters GLUT-1-4.
Reckzeh E, Waldmann H
Chembiochem. 2019; 21(1-2):45-52.
PMID: 31553512
PMC: 7004114.
DOI: 10.1002/cbic.201900544.
Functions of pancreatic stellate cell-derived soluble factors in the microenvironment of pancreatic ductal carcinoma.
Wu Q, Tian Y, Zhang J, Zhang H, Gu F, Lu Y
Oncotarget. 2017; 8(60):102721-102738.
PMID: 29254283
PMC: 5731993.
DOI: 10.18632/oncotarget.21970.
Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.
Koo J, Nam M, Jung Y, Yoo J, Kim D, Kim G
BMC Gastroenterol. 2017; 17(1):73.
PMID: 28592228
PMC: 5463383.
DOI: 10.1186/s12876-017-0627-4.